ここから本文です
投稿一覧に戻る

サンバイオを応援する掲示板の掲示板

8824

kir***** 2019年5月26日 18:24

>>8820

これでしょうか？

h t t p s://clinicaltrials.gov/ct2/show/NCT02448641


Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke (ACTIsSIMA)
ClinicalTrials.gov Identifier: NCT02448641

Study Design

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 156 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Study Start Date : January 2016
Estimated Primary Completion Date : May 30, 2019
Estimated Study Completion Date : September 30, 2019

サンバイオを応援する掲示板 これでしょうか？ h t t p s://clinicaltrials.gov/ct2/show/NCT02448641 Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke (ACTIsSIMA) ClinicalTrials.gov Identifier: NCT02448641 Study Design Study Type : Interventional (Clinical Trial) Estimated Enrollment : 156 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Outcomes Assessor) Primary Purpose: Treatment Official Title: A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke Study Start Date : January 2016 Estimated Primary Completion Date : May 30, 2019 Estimated Study Completion Date : September 30, 2019

開く

投稿一覧に戻る